Subclinical Hypothyroidism: Treatment

When to Treat (Indications)

• Patients over 65 with mildly elevated TSH (5–10 mIU/L) — studies show no improvement in symptoms or quality of life
• Asymptomatic patients with TSH < 10 mIU/L who have no risk factors — annual monitoring is the preferred approach

What to Confirm Before Starting Treatment

How to Treat

• Starting dose: Low, typically 25–50 μg/day, to avoid precipitating cardiac symptoms
• Goal: Normalize TSH, ideally to the lower half of the normal reference range
• Monitoring: Recheck TSH every 6–8 weeks after starting or changing dose, then annually once stable
• Titration: Adjust in 12.5–25 μg increments

Liothyronine (T3) alone or combination T4/T3 therapy is not indicated for subclinical hypothyroidism. Combination therapy has not shown benefit over LT4 monotherapy in randomized trials. — Goldman-Cecil Medicine, p. 2903; Harrison's 22E, p. 3075

Special Populations

• TSH > upper pregnancy-specific limit warrants treatment
• TSH ≥ 10 mIU/L in pregnancy is treated as overt hypothyroidism
• TPO antibody positivity + TSH > 4 mIU/L synergistically raises risk of miscarriage and preterm delivery
• Target TSH: 0.5–2.5 mIU/L (trimester-specific range preferred)
• Monitor every 4 weeks until at least 18 weeks' gestation
• (Creasy & Resnik's Maternal-Fetal Medicine, p. 1505)

• Treatment of subclinical hypothyroidism does not improve symptoms or quality of life in this group
• If TSH is mildly elevated (5–10 mIU/L) and the patient is asymptomatic, annual monitoring is preferred
• Some evidence suggests a mildly elevated TSH in older adults may even be a normal aging variant

Summary Algorithm

Subclinical Hypothyroidism (↑TSH, normal fT4)
        │
        ├─ TSH > 10 mIU/L → TREAT with LT4
        │
        ├─ Pregnancy / wants to conceive → TREAT with LT4
        │
        ├─ TSH 5–10 mIU/L + symptoms, +TPO Ab, ↑LDL, young/middle-aged → Consider LT4 trial
        │
        └─ Asymptomatic, age > 65, TSH 5–10 mIU/L → Annual monitoring; treatment not clearly beneficial

Sources

• Harrison's Principles of Internal Medicine, 22nd Ed. (2025), p. 3075
• Goldman-Cecil Medicine, p. 2903
• Katzung's Basic & Clinical Pharmacology, 16th Ed., p. 1089
• Creasy & Resnik's Maternal-Fetal Medicine, p. 1505

Recent literature note: A 2021 RCT (PMID 33276704, cited in Katzung) and the TRUST trial (Wildisen et al., JAMA Netw Open 2021) found that LT4 did not improve depressive symptoms in older adults with subclinical hypothyroidism, reinforcing conservative management in the elderly.

Patient: Mrs. Rehana Lateef | 55F | Collected: 12-May-2026

Lab Summary & Interpretation

Clinical Assessment

What You Should Do — Step by Step

• Order Free T4 (fT4) — essential to confirm subclinical vs. overt hypothyroidism
• Order Anti-TPO antibodies (TPO Ab) — if positive, progression to overt hypothyroidism is much more likely, and tips the decision toward treating even at TSH 5–10
• Consider Anti-thyroglobulin antibodies if TPO Ab is equivocal

"A trial of treatment may be considered when young or middle-aged patients have symptoms of hypothyroidism or risk of heart disease." — Harrison's 22E

• If TPO Ab positive → Treat with LT4 (high risk of progression; also reduces miscarriage risk, though less relevant at 55)
• If symptomatic → Treat with LT4 (25–50 µg/day starting dose)
• If asymptomatic + TPO Ab negative → Recheck TSH in 3 months to confirm persistence, then decide

Since she is 55 years old, not elderly (> 65), a treatment trial is reasonable if she has any symptoms or positive antibodies.

• eGFR 68 = CKD G2 (mildly reduced) — note that hypothyroidism itself can reduce GFR
• If TSH is corrected and eGFR improves, it confirms the thyroid was contributing
• Re-check renal function in 3–6 months
• No dose adjustment needed for LT4 in CKD G2, but monitor closely

• Start at 25–50 µg/day (lower end given her age, 55)
• Recheck TSH in 6–8 weeks
• Target TSH: lower half of normal range (~0.5–2.5 µIU/mL)
• Counsel her to take LT4 on an empty stomach, ≥30 min before breakfast
• Separate from calcium supplements, iron — both can impair absorption

• Both are normal — no action needed
• Worth noting: B12 deficiency can mimic hypothyroid symptoms (fatigue, cognitive slowing), so it's good these were checked and are normal

Summary Plan

1. Order: Free T4 + TPO antibodies
2. Clinical history: Screen for hypothyroid symptoms
3. Confirm TSH elevation persistent (if not already done previously)
4. If TPO Ab (+) or symptomatic → Start LT4 25–50 µg/day
5. If asymptomatic, TPO Ab (−) → Recheck TSH in 3 months
6. Monitor eGFR at 3–6 months (may improve with thyroid correction)
7. Annual TSH once stable